から減少の結果

147 billion

206 million

5 million

63420

to ~240 options

options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications

とは何か 'alemtuzumab'? に定義されています Alemtuzumab - Alemtuzumab Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma . Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived. よりたくさんの Alemtuzumab (marketed as Campath , MabCampath or Campath-1H ) is a monoclonal antibody used in the treatment of chronic lymphocytic leukemia (CLL) and T-cell lymphoma . Alemtuzumab targets CD52 , a protein present on the surface of mature lymphocytes , but not on the stem cells from which these lymphocytes were derived. It is used as second line therapy for CLL. It was approved by the Food and Drug Administration for patients who have been treated with alkylating agents and who have failed fludarabine therapy. less diagnoses treated with 'alemtuzumab' 1 - 5 of 5 診断 慢性リンパ性白血病 cancer of white blood cells ウェブ検索: Alemtuzumab および 慢性リンパ性白血病 転移 spread of malignant tumors to other body sites ウェブ検索: Alemtuzumab および 転移 悪性腫瘍 cancer ウェブ検索: Alemtuzumab および 悪性腫瘍 移植片対宿主反応 complication of organ transplantation ウェブ検索: Alemtuzumab および 移植片対宿主反応 好酸球増加症候群 multisystem disease from increase in a type of white blood cell ウェブ検索: Alemtuzumab および 好酸球増加症候群 related procedures when taking 'alemtuzumab' 1 - 5 of 151 手順 CTの胸部 ウェブ検索: Alemtuzumab および CTの胸部 CTスキャン ウェブ検索: Alemtuzumab および CTスキャン 完全な血液カウント ウェブ検索: Alemtuzumab および 完全な血液カウント 中心静脈カテーテル ウェブ検索: Alemtuzumab および 中心静脈カテーテル 中心静脈カテーテルの超音波チップ ウェブ検索: Alemtuzumab および 中心静脈カテーテルの超音波チップ 腹部のCATスキャンを ウェブ検索: Alemtuzumab および 腹部のCATスキャンを CTの骨盤 ウェブ検索: Alemtuzumab および CTの骨盤 染色体分析 ウェブ検索: Alemtuzumab および 染色体分析 血清免疫グロブリン ウェブ検索: Alemtuzumab および 血清免疫グロブリン 腹部MRI検査 MRI of abdominal contents ウェブ検索: Alemtuzumab および 腹部MRI検査 脳脊髄液の分析 ウェブ検索: Alemtuzumab および 脳脊髄液の分析 脳脊髄液の開口部の圧力 ウェブ検索: Alemtuzumab および 脳脊髄液の開口部の圧力 化学療法 Use of chemical substances to treat disease ウェブ検索: Alemtuzumab および 化学療法 細胞診 ウェブ検索: Alemtuzumab および 細胞診 フローサイトメトリー ウェブ検索: Alemtuzumab および フローサイトメトリー 免疫 ウェブ検索: Alemtuzumab および 免疫 免疫療法 ウェブ検索: Alemtuzumab および 免疫療法 腰椎穿刺 ウェブ検索: Alemtuzumab および 腰椎穿刺 リンパ節生検 ウェブ検索: Alemtuzumab および リンパ節生検 磁気共鳴イメージングMRI検査 ウェブ検索: Alemtuzumab および 磁気共鳴イメージングMRI検査 詳細については、ログインしてください、ログイン情報（クリックしてログインする）無料です related medication for 'alemtuzumab' 1 - 5 of 84 薬 chlorambucil ウェブ検索: Alemtuzumab および chlorambucil rituximab ウェブ検索: Alemtuzumab および rituximab vincristine ウェブ検索: Alemtuzumab および vincristine cyclophosphamide ウェブ検索: Alemtuzumab および cyclophosphamide doxorubicin ウェブ検索: Alemtuzumab および doxorubicin fludarabine ウェブ検索: Alemtuzumab および fludarabine methotrexate ウェブ検索: Alemtuzumab および methotrexate thalidomide ウェブ検索: Alemtuzumab および thalidomide 5-fluorouracil (5-fu) ウェブ検索: Alemtuzumab および 5-fluorouracil (5-fu) 6-mercaptopurine (6-mp) ウェブ検索: Alemtuzumab および 6-mercaptopurine (6-mp) actinomycin-d ウェブ検索: Alemtuzumab および actinomycin-d alkylating agents ウェブ検索: Alemtuzumab および alkylating agents altretamine ウェブ検索: Alemtuzumab および altretamine anastrozole ウェブ検索: Alemtuzumab および anastrozole anti tumor antibiotics ウェブ検索: Alemtuzumab および anti tumor antibiotics antimetabolites ウェブ検索: Alemtuzumab および antimetabolites arsenic trioxide ウェブ検索: Alemtuzumab および arsenic trioxide bevacizumab ウェブ検索: Alemtuzumab および bevacizumab bexarotene ウェブ検索: Alemtuzumab および bexarotene bicalutamide ウェブ検索: Alemtuzumab および bicalutamide 詳細については、ログインしてください、ログイン情報（クリックしてログインする）無料です 医師は、次の種類に関連している 'Alemtuzumab'. 医師の関連する型 'family practitioner, internist, oncologist' show local physicians 郵便番号 して下さいローカル 星のトピックに関連性はない評価を表す より その結果、コンピュータを見つけるのに役立つ場合は医師のアドバイスに生成される. MEDgleを完了させるかは、プロバイダとの専門医師やクレームの正確な提案では特定のタイプをお勧めしていません. ウェブ検索結果調査のための 'alemtuzumab'? その結果 1 - 50 - Alemtuzumab Alemtuzumab - Wikipedia, the free encyclopedia Alemtuzumab is also used in some conditioning regimens for bone marrow ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ... http://en.wikipedia.org/wiki/Alemtuzumab   en.wikipedia.org - summary Alemtuzumab Drug details for Alemtuzumab. ... Alemtuzumab may be used by itself or in combination with other drugs to treat ... Alemtuzumab is sometimes used in clinical ... http://www.webmd.com/cancer/alemtuzumab   www.webmd.com - summary ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ... Read more about the prescription drug ALEMTUZUMAB - INJECTABLE. ... WARNING: Infrequently, alemtuzumab may cause serious (sometimes fatal) side ... http://www.medicinenet.com/alemtuzumab-injectable/article.htm   www.medicinenet.com - summary Alemtuzumab - Yahoo! Health Before receiving alemtuzumab, tell your doctor if you have heart disease, a ... What is the most important information I should know about alemtuzumab? ... http://health.yahoo.com/leukemia-medications/alemtuzumab/hea...   health.yahoo.com - summary alemtuzumab medical facts from Drugs.com Physician reviewed alemtuzumab patient information - includes alemtuzumab description, dosage and directions. ... 6 months after you stop using alemtuzumab. ... http://www.drugs.com/mtm/alemtuzumab.html   www.drugs.com - summary MedlinePlus Drug Information: Alemtuzumab Injection Alemtuzumab injection may cause a decrease in the number of blood cells made by ... At first, alemtuzumab injection is usually given in gradually increasing doses ... http://www.nlm.nih.gov/medlineplus/druginfo/meds/a608053.html   www.nlm.nih.gov - summary Alemtuzumab in chronic lymphocytic leukemia What toxicities are associated with the use of alemtuzumab? Which patients are more likely?or less likely?to benefit from treatment with alemtuzumab? ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1899355   www.pubmedcentral.nih.gov - summary Alemtuzumab (Intravenous Route) - MayoClinic.com Mayo Clinic offers award-winning medical and health information and tools for healthy living. ... Alemtuzumab is a monoclonal antibody. ... http://www.mayoclinic.com/health/drug-information/DR601635/METHOD=print   www.mayoclinic.com - summary Campath (Alemtuzumab) Drug Information: Uses, Side Effects, Drug ... Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. http://www.rxlist.com/campath-drug.htm   www.rxlist.com - summary Mycobacterium haemophilum Infection after Alemtuzumab Treatment | CDC EID Alemtuzumab causes profound and prolonged lymphocyte depletion, which ... Immediately before receiving alemtuzumab, he had been given rituximab for 3 months. ... http://www.cdc.gov/eid/content/14/11/1821.htm   www.cdc.gov - summary Alemtuzumab: Drug Information Provided by Lexi-Comp: Merck Manual ... Alemtuzumab: Reports of Infection-Related Fatalities - November 2008 ... Use of alemtuzumab as consolidation therapy is presently not approved in Canada. ... http://www.merck.com/mmpe/print/lexicomp/alemtuzumab.html   www.merck.com - summary Definition of alemtuzumab - NCI Dictionary of Cancer Terms The Nation's Investment in Cancer Research FY 2010 ... alemtuzumab. A type of monoclonal antibody used in the treatment of leukemia. ... http://www.nci.nih.gov/Templates/db_alpha.aspx?CdrID=44851   www.nci.nih.gov - summary Discovery Health :: Drug Reference :: Select Drug Get the scoop on the interaction between the drugs that you select to test against. ... Alemtuzumab can lower the blood cells that help your body fight infections. ... http://health.discovery.com/webapps/drugreference.do?drug=41388&pagetype=results   health.discovery.com - summary Clinical Study: 05-H-0242, A Pilot Study of Alemtuzumab (Campath) in ... Clinical Study Summary Sheet for 05-H-0242 ... Because alemtuzumab destroys lymphocytes, it may be effective in treating aplastic anemia. ... http://clinicalstudies.info.nih.gov/detail/A_2005-H-0242.html   clinicalstudies.info.nih.gov - summary Alemtuzumab facts and comparsions at Drugs.com All about Alemtuzumab. View complete and up to date Alemtuzumab information - part of the Drugs.com trusted medication database. http://www.drugs.com/cdi/alemtuzumab.html   www.drugs.com - summary Aplastic Anemia - Evaluation, Treatment and Research at the National ... The National Heart, Lung and Blood Institute is actively seeking patients with ... Alemtuzumab (Campath) for Refractory or Relapsed Severe Aplastic Anemia ... http://patientrecruitment.nhlbi.nih.gov/AplasticAnemia.aspx   patientrecruitment.nhlbi.nih.gov - summary Drug Information for Alemtuzumab IV - WebMD Find medical information for Alemtuzumab IV including side effects, drug interactions, images and pictures, medication uses, warnings, user ratings and reviews. http://www.webmd.com/drugs/drug-21057-Alemtuzumab%20IV.aspx?...   www.webmd.com - summary Phase II study of alemtuzumab in chronic lymphoproliferative disorders. Alemtuzumab was given intravenously at doses of 3 mg, 10 mg, and 30 mg on 3 ... CONCLUSIONS: Alemtuzumab has a high response rate in patients with chronic ... http://www.ncbi.nlm.nih.gov/pubmed/12910522   www.ncbi.nlm.nih.gov - summary Alemtuzumab - Yahoo! Health Alemtuzumab is a monoclonal antibody that attaches itself to a protein called CD52. ... Alemtuzumab may be used by itself or in combination with other drugs to treat ... http://health.yahoo.com/leukemia-medications/alemtuzumab/healthwise--tv7623.html   health.yahoo.com - summary R. equi Infection after Alemtuzumab Therapy | CDC EID Alemtuzumab, an anti-CD52 monoclonal antibody, causes ... Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. ... http://www.cdc.gov/eid/content/13/12/1942.htm   www.cdc.gov - summary ALEMTUZUMAB - INJECTABLE (Campath) side effects, medical uses, and drug ... Read doctor-produced health and medical information written for you to make informed decisions about ... View All 5 alemtuzumab-injectable Doctor's & Expert's ... http://www.medicinenet.com/alemtuzumab-injectable/index.htm   www.medicinenet.com - summary Sunitinib - Wikipedia, the free encyclopedia Description of targeted therapy drug includes indications for therapy ... myeloid: CD52 (Alemtuzumab) L+M: CD33 (Gemtuzumab) Tyrosine kinase inhibitors ("-nib" ... http://en.wikipedia.org/wiki/Sunitinib   en.wikipedia.org - summary Chronic Lymphocytic Leukemia (CLL): Leukemias: Merck Manual Home Edition Introduction· Acute Lymphocytic Leukemia (ALL)· Acute Myelocytic Leukemia (AML) ... or alemtuzumab Some Trade Names. CAMPATH ) are considered. ... http://www.merck.com/mmhe/sec14/ch176/ch176d.html   www.merck.com - summary Pharmacokinetics of alemtuzumab in combination with fludarabine in ... Following alemtuzumab dose escalation (3 to 10 to 30 mg over three days) ... Plasma concentrations of alemtuzumab were determined using the previously ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2625426   www.pubmedcentral.nih.gov - summary Alemtuzumab consumer information from Drugs.com Alemtuzumab patient information. ... Pregnancy?Alemtuzumab may cause harm to the fetus when ... You should avoid becoming pregnant while receiving alemtuzumab. ... http://www.drugs.com/cons/Alemtuzumab.html   www.drugs.com - summary Cytomegalovirus retinitis after hematopoietic stem cell transplantation ... Cytomegalovirus retinitis after hematopoietic stem cell transplantation with alemtuzumab. ... transplantation (HSCT) using an alemtuzumab-based (Campath-1H, Genzyme, ... http://www.ncbi.nlm.nih.gov/pubmed/18562004   www.ncbi.nlm.nih.gov - summary Guarded Optimism for Experimental MS Drug - Neurology (Brain and Nerve ... Explains neurology (brain and nerve) conditions; includes symptoms, causes, ... He agrees that alemtuzumab's role in MS treatment remains to be determined. ... http://www.medicinenet.com/guide.asp?s=rss&a=93604&k=interferon_Specialty   www.medicinenet.com - summary Bevacizumab - Wikipedia, the free encyclopedia myeloid: CD52 (Alemtuzumab) L+M: CD33 (Gemtuzumab) Tyrosine kinase inhibitors ("-nib" ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ... http://en.wikipedia.org/wiki/Bevacizumab   en.wikipedia.org - summary Population pharmacokinetics?pharmacodynamics of alemtuzumab (Campath ... Alemtuzumab pharmacokinetics were best characterized by a two-compartment model ... Alemtuzumab is currently administered as a 2-h intravenous infusion under a dose ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2000651   www.pubmedcentral.nih.gov - summary Combination therapy with fludarabine and rituximab followed by ... Toxicity with alemtuzumab included infusion-related toxicity, myelosuppression, ... The generalized use of alemtuzumab as consolidation therapy cannot yet be ... http://www.ncbi.nlm.nih.gov/pubmed/18189296?ordinalpos=3&ito...   www.ncbi.nlm.nih.gov - summary Drugs A-Z List - A on RxList Browse an A-Z list of Brand and Generic drugs to learn about your prescription medication. ... Alemtuzumab (Campath) Alendronate Sodium (Fosamax) ... http://www.rxlist.com/drugs/alpha_a.htm   www.rxlist.com - summary Therapies under investigation for multiple sclerosis - Wikipedia, the ... Therefore, all patients receiving alemtuzumab should have their platelet count ... Information from GenZyme on its clinical trial for Alemtuzumab ... http://en.wikipedia.org/wiki/Therapies_under_investigation_f...   en.wikipedia.org - summary alimta and Alemtuzumab Drug Interactions alimta and Alemtuzumab Drug Interactions. Drug-drug and drug-food interactions between alimta and Alemtuzumab ... Alemtuzumab alone may cause severe and ... http://www.drugs.com/drug-interactions/alimta_d05047_alemtuzumab_d04756.html   www.drugs.com - summary Chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia is a (cancer) of the white blood cells (lymphocytes) characterized by a slow, progressive ... drug alemtuzumab (Campath), which ... http://adam.about.com/encyclopedia/000532trt.htm?terms=chron...   adam.about.com - summary Drug Information for M-R-Vax II SubQ - WebMD Find medical information for M-R-Vax II SubQ including side effects, drug interactions, ... LIVE VIRAL VACCINES/ALEMTUZUMAB. LIVE VACCINES/ANAKINRA; RILONACEPT ... http://www.webmd.com/drugs/drug-9298-M-R-Vax+II+SubQ.aspx?dr...   www.webmd.com - summary Health Encyclopedia from A to Z on Yahoo! Health Health encyclopedia of diseases and conditions covering signs, symptoms, causes, incidence, risk, prevention, tests, diagnosis, treatment, complications and side effects. http://health.yahoo.com/ency/   health.yahoo.com - summary Alemtuzumab in the up-front setting. Alemtuzumab is a humanized chimeric monoclonal antibody targeting CD52. ... Early trials showed alemtuzumab's value in refractory disease and helped to ... http://www.ncbi.nlm.nih.gov/pubmed/18728844?ordinalpos=1&ito...   www.ncbi.nlm.nih.gov - summary Clinical Study: 03-H-0249, A Randomized Trial of Immunosupression in ... Clinical Study Summary Sheet for 03-H-0249 ... Drug: Alemtuzumab (Campath-1H) Drug: Thymoglobulin (r-ATG) Drug: Cyclosporine (CsA) ... http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2003-H-0249.html   clinicalstudies.info.nih.gov - summary Imatinib - Wikipedia, the free encyclopedia Imatinib. From Wikipedia, the free encyclopedia (Redirected from Glivec) ... Tositumomab) · other (Alemtuzumab, Bevacizumab, Edrecolomab, Gemtuzumab) ... http://en.wikipedia.org/wiki/Glivec   en.wikipedia.org - summary Drugs.com | Drug Interactions Checker Drug Interaction Checker. Check for drug-drug and drug-food interactions ... Browse all medications A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ... http://www.drugs.com/data/channel/md/drkoop.cfm?int=2&list=1...   www.drugs.com - summary Prolymphocytic leukemia. With the introduction of alemtuzumab, most patients who progressed despite ... We recommend alemtuzumab as initial therapy and offer stem cell transplant (SCT) ... http://www.ncbi.nlm.nih.gov/pubmed/15869731   www.ncbi.nlm.nih.gov - summary Drug Information for Measles Virus Vaccine SubQ - WebMD Find medical information for Measles Virus Vaccine SubQ including side effects, drug ... LIVE VIRAL VACCINES/ALEMTUZUMAB. LIVE VACCINES/ANAKINRA; RILONACEPT ... http://www.webmd.com/drugs/drug-8804-Measles%20Virus%20Vacci...   www.webmd.com - summary Definition of alemtuzumab - National Cancer Institute Drug Dictionary The Nation's Investment in Cancer Research FY 2010 ... alemtuzumab ... Alemtuzumab is an IgG1 kappa with human variable framework and constant regions, ... http://wwwicic.nci.nih.gov/Templates/drugdictionary.aspx?CdrID=37783   wwwicic.nci.nih.gov - summary Milatuzumab - Wikipedia, the free encyclopedia STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - MILATUZUMAB, ... Afutuzumab, Alemtuzumab, Bevacizumab/Ranibizumab, Bivatuzumab mertansine, ... http://en.wikipedia.org/wiki/Milatuzumab   en.wikipedia.org - summary Neoplasia: Targeting CD37-positive lymphoid malignancies with a novel ... Alemtuzumab was produced by Ilex Pharmaceuticals (San Antonio, TX) and purchased ... Ability of trastuzumab, CD37-SMIP, alemtuzumab, or rituximab to mediate ADCC was ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1988922   www.pubmedcentral.nih.gov - summary Rituximab and alemtuzumab induce a nonclassic, caspase-independent ... The monoclonal antibodies (MoAbs) alemtuzumab (anti-CD52) and rituximab (anti ... Both alemtuzumab and rituximab also killed freshly isolated CLL cells, with a ... http://www.ncbi.nlm.nih.gov/pubmed/15309525?ordinalpos=1&ito...   www.ncbi.nlm.nih.gov - summary Drugs A-Z List - C on RxList Browse an A-Z list of Brand and Generic drugs to learn about your prescription medication. ... Campath (Alemtuzumab) Campral (Acamprosate Calcium) ... http://www.rxlist.com/drugs/alpha_c.htm   www.rxlist.com - summary Smallpox Vaccine (Injection Route) - MayoClinic.com Mayo Clinic offers award-winning medical and health information and ... Alemtuzumab. Altretamine. Amonafide. Amsacrine. Asparaginase. Azacitidine. Azathioprine ... http://www.mayoclinic.com/health/drug-information/DR602529/METHOD=print   www.mayoclinic.com - summary MedlinePlus Drug Information: Drugs beginning with Ca Caduet® (as a combination product containing Amlodipine and Atorvastatin) see Amlodipine ... Campath® see Alemtuzumab Injection ... http://www.nlm.nih.gov/medlineplus/druginfo/drug_Ca.html   www.nlm.nih.gov - summary Camptothecin - Wikipedia, the free encyclopedia Camptothecin (CPT) is a cytotoxic quinoline alkaloid which inhibits the DNA ... Tositumomab) · other (Alemtuzumab, Bevacizumab, Edrecolomab, Gemtuzumab) ... http://en.wikipedia.org/wiki/Camptothecins   en.wikipedia.org - summary もっと表示 1  2

Chat with eNurse Kim about 'Alemtuzumab' or something else! 迅速な事実 related diagnosis category oncology 血液学的 dermatology gastrointestinal 免疫システム